Stay updated on CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Sign up to get notified when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.

Latest updates to the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record now indicates that the trial is no longer looking for participants, signaling that enrollment has been halted. This update also accompanies a revision label of v3.6.0, replacing the prior v3.5.5.SummaryDifference0.7%

- Check15 days agoChange DetectedThe record history shows a new latest revision labeled v3.5.5, superseding the previous v3.5.4, reflecting an update to the page's historical metadata.SummaryDifference0.1%

- Check37 days agoChange DetectedNew revision entry added: 'Revision: v3.5.4'. The previous revision 'Revision: v3.5.3' is removed, indicating an updated release note for the record history.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s interface revision number has been updated from version v3.5.2 to v3.5.3, reflecting a site software/release update rather than a modification to the trial record.SummaryDifference0.1%

- Check66 days agoChange DetectedNew revision v3.5.2 added; revision v3.5.0 removed.SummaryDifference0.1%

- Check94 days agoChange DetectedNew revision entry v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.